Evidence map›Paper›PMID 25301707›Full record

ArticleBlood2015

SLAP/SLAP2 prevent excessive platelet (hem)ITAM signaling in thrombosis and ischemic stroke in mice.

Deya Cherpokova, Markus Bender, Martina Morowski, Peter Kraft, Michael K Schuhmann, Sarah M Akbar, Cheryl S Sultan, Craig E Hughes, Christoph Kleinschnitz, Guido Stoll and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Deya CherpokovaDepartment of Experimental Medicine, University Hospital Würzburg and Rudolf Virchow Center for Experimental Biomedicine, Würzburg, Germany;
Markus BenderDepartment of Experimental Medicine, University Hospital Würzburg and Rudolf Virchow Center for Experimental Biomedicine, Würzburg, Germany;ORCID http://orcid.org/0000-0002-2381-116X
Martina MorowskiDepartment of Experimental Medicine, University Hospital Würzburg and Rudolf Virchow Center for Experimental Biomedicine, Würzburg, Germany;
Peter KraftDepartment of Neurology, University Hospital Würzburg, Würzburg, Germany;
Michael K SchuhmannDepartment of Neurology, University Hospital Würzburg, Würzburg, Germany;
Sarah M AkbarSchool of Biosciences, College of Life and Environmental Sciences, and.
Cheryl S SultanSchool of Biosciences, College of Life and Environmental Sciences, and.
Craig E HughesCentre for Cardiovascular Sciences, School of Clinical and Experimental Medicine, Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and.
Christoph KleinschnitzDepartment of Neurology, University Hospital Würzburg, Würzburg, Germany;
Guido StollDepartment of Neurology, University Hospital Würzburg, Würzburg, Germany;
Leonard L DragoneDepartments of Pediatrics and Immunology, University of Colorado, School of Medicine, Aurora, CO.
Steve P WatsonCentre for Cardiovascular Sciences, School of Clinical and Experimental Medicine, Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; and.
Michael G TomlinsonSchool of Biosciences, College of Life and Environmental Sciences, and.ORCID http://orcid.org/0000-0002-1189-0091
Bernhard NieswandtDepartment of Experimental Medicine, University Hospital Würzburg and Rudolf Virchow Center for Experimental Biomedicine, Würzburg, Germany;
Universitätsklinikum Würzburg · DEUniversity of Birmingham · GBUniversity of Colorado Denver · US

Funding

British Heart Foundation FS/08/062/25797Wellcome Trust 088410
6 · The paper itself

Abstract

Glycoprotein VI and C-type lectin-like receptor 2 are essential platelet activating receptors in hemostasis and thrombo-inflammatory disease, which signal through a (hem)immunoreceptor tyrosine-based activation motif (ITAM)-dependent pathway. The adapter molecules Src-like adapter proteins (SLAP and SLAP2) are involved in the regulation of immune cell surface expression and signaling, but their function in platelets is unknown. In this study, we show that platelets expressed both SLAP isoforms and that overexpression of either protein in a heterologous cell line almost completely inhibited glycoprotein VI and C-type lectin-like receptor 2 signaling. In mice, single deficiency of SLAP or SLAP2 had only moderate effects on platelet function, whereas double deficiency of both adapters resulted in markedly increased signal transduction, integrin activation, granule release, aggregation, procoagulant activity, and thrombin generation in response to (hem)ITAM-coupled, but not G protein-coupled, receptor activation. In vivo, constitutive SLAP/SLAP2 knockout mice displayed accelerated occlusive arterial thrombus formation and a dramatically worsened outcome after focal cerebral ischemia. This was attributed to the absence of both adapter proteins in platelets, as demonstrated by adoptive transfer of Slap(-/-)/Slap2(-/-) platelets into wild-type mice. Our results establish SLAP and SLAP2 as critical inhibitors of platelet (hem)ITAM signaling in the setting of arterial thrombosis and ischemic stroke.

Indexed as

Signal TransductionAdaptor Proteins, Signal TransducingAmino Acid MotifsAnimalsBlood PlateletsBrain InfarctionCarotid ArteriesCell MembraneCrotalid VenomsInflammationIntracellular Signaling Peptides and ProteinsLectins, C-TypeMembrane ProteinsMiceMice, Inbred BALB CMice, Inbred C57BLAdaptor Proteins, Signal TransducingCbl protein, mouseconvulxinCrotalid VenomsIntracellular Signaling Peptides and ProteinsLat protein, mouseLectins, C-TypeMembrane ProteinsPhosphoproteinsPlatelet Membrane Glycoproteinsplatelet membrane glycoprotein VIProtein-Tyrosine KinasesProto-Oncogene Proteins c-cblProto-Oncogene Proteins pp60(c-src)Sla2 protein, mouseSla protein, mouseSnake VenomsSyk KinaseSyk protein, mouse

Identifiers

PMID25301707
PMCPMC4281827
OpenAlexW1974381086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.